Status:

RECRUITING

Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort

Lead Sponsor:

Northwell Health

Conditions:

Prostate Cancer

Magnetic Resonance Imaging

Eligibility:

MALE

40-55 years

Phase:

NA

Brief Summary

To determine whether using bpMRI in subjects who are at high risk of developing prostate cancer in conjunction with PSA will improve prostate cancer screening protocols.

Detailed Description

The Investigators propose a pilot study which utilizes bpMRI in conjunction with PSA in the early detection of clinically significant prostate cancer in a high-risk group. Our study would focus on the...

Eligibility Criteria

Inclusion

  • PSA between 1.0 and 2.5 ng/dL
  • High risk for prostate cancer, i.e. Black or they have a first degree relative with history of prostate cancer (father, brother) or specific genetic syndromes i.e. BRCA 1/2, HOX B13, Lynch syndrome, ATM, CHEK2
  • Patient is willing to participated in prostate cancer screening
  • Patient is capable of giving informed consent

Exclusion

  • Nodularity or firmness of prostate on exam
  • Patient has undergone a prior biopsy or prostate surgery
  • Patient is taking 5-alpha reductase inhibitors to manage benign prostatic hyperplasia, as this can significantly alter PSA levels.
  • Patient has a history of UTI or prostatitis in the preceding 6 months, as this can significantly alter PSA levels.
  • Patient has a contraindication to MRI, these include but are not limited to pacemakers, neurostimulator devices, metal cardiac valves, certain tattoos, or foreign bodies
  • Participants that experience claustrophobia, anxiety and/or vertigo when moved inside the scanner
  • The participant cannot tolerate lying flat for the study duration

Key Trial Info

Start Date :

August 15 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 31 2028

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT05384535

Start Date

August 15 2022

End Date

October 31 2028

Last Update

November 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Cynthia Knauer

Lake Success, New York, United States, 11042

Utility of Biparametric MRI (Magnetic Resonance Imaging) as a Screening Tool for Prostate Cancer in a High-Risk Cohort | DecenTrialz